UiPath eyed for a potential 3x on a short squeeze and AI turnaround
UiPath is being pitched as a cheap software recovery story that could triple, good news for risk-tolerant investors betting on its shift from plain automation to AI.
- UiPath automates repetitive back-office tasks like insurance claims and bank compliance where 100% accuracy matters and AI chatbots can't be trusted alone.
- Small customers are quitting to cut costs, but big spenders are growing fast — clients spending over $1 million jumped 18%, and AI now features in most of its largest deals.
- The company is finally profitable, generates strong cash, sits on over a billion dollars in cash, and is buying back its own stock.
- Short interest has climbed above 30%, raising the odds of a squeeze if the business keeps improving.
- Wall Street is cautious and mostly on the sidelines with low price targets, waiting for proof that AI revenue accelerates.
Outlook: Earnings on September 3rd are the key test — a jump in recurring revenue could push the stock sharply higher, while a miss keeps the "prove it" doubts alive.